Interview with Dr. Stefan Walzer What is a DIGA?Why is Germany so important for DIGAs? Nowadays, there are a couple of available apps being used in several countries that collect user information, such as heart rate combined with algorithms that calculate certain health risks that the user may be vulnerable to. What differentiates these apps …
Interview with Antoine Regnault Why do companies want to develop new patient-reported outcomes (PRO)?How does the process start when we want to develop a new questionnaire?What are the key areas to look into for understanding the quality of a PRO?What guidelines exist on developing new PROs? In today’s episode, Antoine and I answer these questions …
What does it take to develop good patient-reported outcomes? Read More »
Interview with Jenny Devenport What is medical affairs? Launch and Lifecycle?How has this area evolved over the last 2 decades?What is the current state across the industry in terms of the role of statistics in this space? This is a series of episodes and today’s content is the first episode. Join Jenny and I while …
What is the current state of Launch and Lifecycle work and how did it evolve? Read More »
Interview with Miguel Hernan When there is one topic, which is really hot, it’s causal inference. I’ve got in contact with it about 20 years ago when analysing observational studies and when nobody working on clinical trials would consider it. But now – after the introduction of the estimands framework – this becomes part of …